Colistin MIC variability by method for contemporary clinical isolates of multidrug-resistant Gram-negative bacilli
about
A pharmacokinetic-pharmacodynamic (PKPD) model based on in vitro time-kill data predicts the in vivo PK/PD index of colistin.The global challenge of carbapenem-resistant Enterobacteriaceae in transplant recipients and patients with hematologic malignanciesA New Combination of a Pleuromutilin Derivative and Doxycycline for Treatment of Multidrug-Resistant Acinetobacter baumannii.Resistance to colistin associated with a single amino acid change in protein PmrB among Klebsiella pneumoniae isolates of worldwide origin.Polymyxins: Antibacterial Activity, Susceptibility Testing, and Resistance Mechanisms Encoded by Plasmids or Chromosomes.Heteroresistance to colistin in Klebsiella pneumoniae associated with alterations in the PhoPQ regulatory system.The role of vancomycin in addition with colistin and meropenem against colistin-sensitive multidrug resistant Acinetobacter baumannii causing severe infections in a Paediatric Intensive Care UnitDiversity of multi-drug resistant Acinetobacter baumannii population in a major hospital in Kuwait.Reply to "Reliability of Gradient Diffusion Methods for Detection of Acquired Colistin Resistance"Verification of an Automated, Digital Dispensing Platform for At-Will Broth Microdilution-Based Antimicrobial Susceptibility TestingIncreased prevalence of antibiotic-resistant E. coli in gulls sampled in Southcentral Alaska is associated with urban environmentsGrowth retardation, reduced invasiveness, and impaired colistin-mediated cell death associated with colistin resistance development in Acinetobacter baumanniiSusceptibility testing of the polymyxins: where are we now?To B or not to B, that is the question: is it time to replace colistin with polymyxin B?Optimum treatment strategies for carbapenem-resistant Acinetobacter baumannii bacteremia.Polymyxin B versus colistin: an update.Effects of Treated versus Untreated Polystyrene on Caspofungin In Vitro Activity against Candida Species.Susceptibility Testing for the Polymyxins: Two Steps Back, Three Steps Forward?Colistin and Polymyxin B Susceptibility Testing for Carbapenem-Resistant and mcr-Positive Enterobacteriaceae: Comparison of Sensititre, MicroScan, Vitek 2, and Etest with Broth Microdilution.Colistin: still a lifesaver for the 21st century?Clinical Pharmacokinetics and Pharmacodynamics of Colistin.Mutant prevention concentration of colistin alone and in combination with rifampicin for multidrug-resistant Acinetobacter baumannii.Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on Mortality.Evaluation of polymyxin susceptibility profile among KPC-producing Klebsiella pneumoniae using Etest and MicroScan WalkAway automated system.Cluster-dependent colistin hetero-resistance in Enterobacter cloacae complex.Target site antimicrobial activity of colistin might be misestimated if tested in conventional growth media.In Vitro Synergistic Effects of Antimicrobial Combinations on Extensively Drug-Resistant Pseudomonas aeruginosa and Acinetobacter baumannii Isolates.Comparative Evaluation of Colistin Susceptibility Testing Methods among Carbapenem-Nonsusceptible Klebsiella pneumoniae and Acinetobacter baumannii Clinical IsolatesMolecular Mechanisms of Colistin Resistance in Klebsiella pneumoniae Causing Bacteremia from India-A First Report.In vitro and in vivo activities of tigecycline-colistin combination therapies against carbapenem-resistant Enterobacteriaceae.Activity of colistin in combination with tigecycline or rifampicin against multidrug-resistant Stenotrophomonas maltophilia.Irreproducible and uninterpretable Polymyxin B MICs for Enterobacter cloacae and Enterobacter aerogenesChallenges, Issues and Warnings from CLSI and EUCAST Working Group on Polymyxin Susceptibility Testing.Colistin and Polymyxin B Minimal Inhibitory Concentrations Determined by Etest Found Unreliable for Gram-Negative Bacilli.mcr-1-Positive Colistin-Resistant Escherichia coli in Traveler Returning to Canada from China.First Description of mcr-1-Mediated Colistin Resistance in Human Infections Caused by Escherichia coli in Latin AmericaReliability of Gradient Diffusion Methods for Detection of Acquired Colistin Resistance.Rapid Detection of Polymyxin Resistance in Enterobacteriaceae.To add or not to add polysorbate 80: impact on colistin MICs for clinical strains of Enterobacteriaceae and Pseudomonas aeruginosa and quality controls.Identification and characterization of mcr mediated colistin resistance in extraintestinal Escherichia coli from poultry and livestock in China.
P2860
Q31059319-D05EF125-E00C-446F-84AA-4E4B4602AE3BQ33686940-29AF968C-5FAB-4821-872C-B439714A7C3BQ33792789-A2769DDD-1A83-4E90-905A-DCACA617AA86Q34058244-C7F4E83E-E823-4B97-912D-FA92F668FD4DQ34552966-C36572E7-4B2F-4DF7-9248-8FC24E0FF45BQ35385645-38AB13AA-5F20-4121-9EC9-56838F64ADECQ35794409-62EBC573-96B9-43C2-AA1F-A2CCA2F0966EQ35884241-575B867D-C100-4F67-B5CD-B44F354AB1C0Q37023179-B51E709C-D6AD-4E74-B4E9-CC30B01EB1C5Q37218574-A5FA2F55-5D9A-4896-B2B9-198ABBFF75B8Q37270671-B587F6C6-6DEE-46F8-8EE6-0747155CB328Q37544704-A9ED5CBF-1E3F-4C2A-AA73-CB2C4D70F5FCQ38261390-A3209EE2-CD86-4362-8619-6760EB62CC6FQ38262873-4CAC2356-3173-426B-BB3E-835D3288FE72Q38416932-49CCF1FB-F86A-4060-B5BF-226E09E49E02Q38613051-2ACA3443-7A42-4AB5-922A-86BAAF6F4387Q38637592-6AB1FAC5-B09F-439D-8829-145C452311BCQ38671537-B717AB3F-BFCE-4749-B056-5BAE1209C6B5Q38737560-3ADB4478-3882-4189-97DE-3194CABAD5E1Q38940249-83CF07BE-B7C9-4EFD-B9EE-8B62036FF9E5Q39333751-04C4BF73-EBE3-4A13-AB9D-0547D9C4FAE1Q39503267-414535CF-63B6-4317-97C2-38DCFDDD07F7Q40414282-FE5C57EB-CC18-4822-8E45-776CC7832C3EQ40548894-D2623761-9C86-496D-AEE4-AAE25497CFFEQ40587119-EDFB534A-FC29-4065-843A-6CAD4720FAA6Q40733088-43CFACEC-082A-4582-8C0D-31B93F40EBAFQ40855475-F42C6BD1-C20B-4D87-A1B8-32F28CF080DAQ40898828-A833CF8B-F271-41EA-9695-AF6DAF1F91A1Q40962055-20332A42-DC79-4462-86BA-ED8FC1052C19Q41077618-18838DEB-4BEE-4AE7-9BFC-5BBBE99CF787Q42003718-69AB6C6E-A413-4558-9429-FC10F663686BQ42071550-B7D6B3DC-4A22-4774-9DD8-37F1CB66F8BCQ42090839-79AD7CFB-B641-4E5A-8DB0-67F574CFBF5DQ42283991-1F0A5452-963A-422C-81D9-1B9A2F7E7738Q42339797-79178FE0-8220-462B-A338-41518B515558Q42591068-48F8E716-1D2D-4EAA-B94A-36ADEDB51812Q42591317-0790FFDE-3F43-4A06-9E1D-0F754B0EB2ECQ42762418-5BE224B6-F757-49E3-9A04-B855DB16FCEFQ42932572-8BD31A69-EFE1-44C9-B3B2-93FBCE84A709Q43167627-2DA2036D-60AD-42F0-BD03-D489621D7433
P2860
Colistin MIC variability by method for contemporary clinical isolates of multidrug-resistant Gram-negative bacilli
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Colistin MIC variability by me ...... esistant Gram-negative bacilli
@en
Colistin MIC variability by me ...... esistant Gram-negative bacilli
@nl
type
label
Colistin MIC variability by me ...... esistant Gram-negative bacilli
@en
Colistin MIC variability by me ...... esistant Gram-negative bacilli
@nl
prefLabel
Colistin MIC variability by me ...... esistant Gram-negative bacilli
@en
Colistin MIC variability by me ...... esistant Gram-negative bacilli
@nl
P2860
P356
P1476
Colistin MIC variability by me ...... esistant Gram-negative bacilli
@en
P2093
Janet A Hindler
Romney M Humphries
P2860
P304
P356
10.1128/JCM.03385-12
P407
P577
2013-03-13T00:00:00Z